Sign up to save your podcasts
Or
Share Two Ipilimumab Trials Show Survival Benefit, and More Toxicity
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Two Ipilimumab Trials Show Survival Benefit, and More Toxicity
Dr Weber discusses two studies that show a clear survival advantage with ipilimumab, but at a significant price in toxicity.
View all episodes
By MedscapeDr Weber discusses two studies that show a clear survival advantage with ipilimumab, but at a significant price in toxicity.